Regeneron Pharmaceuticals (REGN) Common Equity (2009 - 2026)
Regeneron Pharmaceuticals (REGN) reported Common Equity of $31.71 billion for Q2 2026, up 5.9% from $29.94 billion a year earlier and up 0.9% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Regeneron Pharmaceuticals posted Common Equity of $31.26 billion, up 6.5% from FY2024.
- Common Equity has increased for five consecutive years, with a five-year compound annual growth rate of 23.2% (FY2020 to FY2025).
- By year, Common Equity came in at $29.35 billion in FY2024 (+13.0%), $25.97 billion in FY2023 (+14.6%), $22.66 billion in FY2022 (+20.8%) and $18.77 billion in FY2021 (+70.2%).
- The Q2 2026 figure ranks as the highest quarterly Common Equity in data going back to Q2 2009.
- Year over year, Common Equity has now increased in each of the last 21 quarters, with growth averaging 8.8% over the last eight quarters.
- Over the past five years, the year-over-year growth in Common Equity ranged from 5.6% (Q3 2025) to 70.4% (Q3 2021).
- Per Business Quant data, the three quarters before Q2 2026 came in at $31.42 billion (Q1 2026), $31.26 billion (Q4 2025) and $30.96 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Regeneron Pharmaceuticals | 91.70 Bn | 57.05 Bn | 4.54 Bn | 33.50 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 33.50 Bn |
| Jun 30, 2026 | 31.71 Bn |
| Mar 31, 2026 | 31.42 Bn |
| Dec 31, 2025 | 31.26 Bn |
| Sep 30, 2025 | 30.96 Bn |
| Jun 30, 2025 | 29.94 Bn |
| Mar 31, 2025 | 29.39 Bn |
| Dec 31, 2024 | 29.35 Bn |
| Sep 30, 2024 | 29.33 Bn |
| Jun 30, 2024 | 28.21 Bn |
| Mar 31, 2024 | 26.99 Bn |
| Dec 31, 2023 | 25.97 Bn |
| Sep 30, 2023 | 24.90 Bn |
| Jun 30, 2023 | 24.02 Bn |
| Mar 31, 2023 | 23.50 Bn |
| Dec 31, 2022 | 22.66 Bn |
| Sep 30, 2022 | 21.44 Bn |
| Jun 30, 2022 | 20.69 Bn |
| Mar 31, 2022 | 19.91 Bn |
| Dec 31, 2021 | 18.77 Bn |
API Access
Regeneron Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();